This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
SUFU WM 2015
Viewing 1-20 of 2893 articles
TRANSCRIPT VIDEO ID 4353 I 092024: Ava Rangnekar - MAAUA - Pelvic Floor Dysfunction and Dyspareunia in Elite Athletes
TRANSCRIPT VIDEO ID 4363 I 101824: EMBARGO Ali Nasrallah - AUA South Central
TRANSCRIPT VIDEO ID 4373 I 102824: EMBARGO Yair Lotan - South Central AUA - Efficacy of Intravesical Nadofaragene Firadenovec-VNCG for Patients with BCG-Unresponsive NMIBC: 36-Month follow-up from a Phase 3 Trial
TRANSCRIPT VIDEO ID 4352 I 092024: Ava Rangnekar - MAAUA - Association Between Current and Pack-Year Smoking History and Urinary Urgency
TRANSCRIPT ID 4370 I 100924: Brian Rini - ESMO 2024 - Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan Versus Everolimus in Participants with Previously Treated Advanced Clear Cell Renal Cell Carcinoma
TRANSCRIPT ID 4370 I 100924: Brian Rini - ESMO 2024 - Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan Versus Everolimus in Participants with Previously Treated Advanced Clear Cell Renal Cell Carcinoma
TRANSCRIPT ID 4364 I 100824: Evan Yu - ESMO 2024 - PSMA-targeted radioligand therapy with 131I-LNTH-1095 plus enzalutamide vs enza alone in chemotherapy-naïve patients whose piflufolastat F 18-avid mCRPC progressed on abiraterone: ARROW
TRANSCRIPT ID 4371 I 101424: Silke Gillessen - ESMO 2024 - Overall Survival Results from the Multi-Arm, Multi-Stage Randomised Platform Trial STAMPEDE
TRANSCRIPT VIDEO ID 4372 I 102824 - EMBARGO - Lisa Lowenstein - South Central AUA - Watchful Waiting
TRANSCRIPT VIDEO ID 4361 I 091024: Martin Miner - Wall Street Journal Article with Dr. Crawford
TRANSCRIPT VIDEO ID 4360 I 090924: Sarah Psutka - 2024 BCAN TT - Unveiling Innovations in Cognitive Resilience During Bladder Cancer Care with (P)Rehabilitation
TRANSCRIPT VIDEO ID 4355 I 090524: Øyvind Bruland - Series on Radiopharmaceuticals in GU Cancers
TRANSCRIPT VIDEO ID 4357 I 090524: Andrea Apolo - 2024 BCAN TT - Bridging Evidence Generation to Practice in Bladder Cancer Care with Implementation Science
TRANSCRIPT ID 4356 I 090924: Volker Wagner - Series on Radiopharmaceuticals in GU Cancers
TRANSCRIPT ID 4347 I 082324: Adam Weiner - International Variations in Adherence to Quality Metrics for Locoregional Prostate Cancer
TRANSCRIPT VIDEO ID 4334 I 100824: DROPBOX TO PREVIEW Jeffrey Humphrey - Series on Radiopharmaceuticals in GU Cancers
TRANSCRIPT ID 4349 I 090324: Rohan Patel - Caring for Sexual and Gender Minority Patients with Genitourinary Cancer: A Primer for Inclusive Practices
TRANSCRIPT VIDEO ID 4354 I 090324: Steve Kregel - "Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
TRANSCRIPT ID 4351 I 083024: Kathy Huen - Misattribution Inaccuracy in U.S. News & World Report Urology Ranking Metrics
TRANSCRIPT VIDEO ID 4350 I 10094: Gautier Marcq - ESMO 2024 - a Phase 1/2 Study of EG-70 (Detalimogene Voraplasmid) Intravesical Monotherapy for Patients with BCG-Unresponsive NMIBC with Carcinoma in Situ
1
2
3
4
5
6
7
8
9
10
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free